BLFS - BioLife Solutions, Inc.
NASDAQ
->
Healthcare
->
Medical Instruments & Supplies
Bothell,
United States
Type: Equity
BLFS price evolution
BLFS
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $22.05 | $29.73 | $35.44 | |
| Short term investments | $12.12 | $15.58 | $16.29 | |
| Net receivables | $17.92 | $18.06 | $18.57 | $18.66 |
| Inventory | $32.18 | $32.5 | $43.41 | $43.46 |
| Total current assets | $89.38 | $88.2 | $111.7 | $120.6 |
| Long term investments | $3.68 | $5.89 | $5.62 | |
| Property, plant & equipment | $42.96 | $38.79 | $38.79 | $40.33 |
| Goodwill & intangible assets | $244.07 | $244.98 | $245.89 | |
| Total noncurrent assets | $286.78 | $289.9 | $292.11 | |
| Total investments | $15.8 | $21.47 | $21.91 | |
| Total assets | $381.65 | $374.98 | $401.6 | $412.71 |
| Current liabilities | ||||
| Accounts payable | $3.84 | $4.21 | $4.98 | $6.94 |
| Deferred revenue | ||||
| Short long term debt | $13.44 | $11.62 | $10.01 | |
| Total current liabilities | $32.17 | $30.82 | $38.66 | $42.18 |
| Long term debt | $8.74 | $11.45 | $29.35 | $32.69 |
| Total noncurrent liabilities | $22.71 | $29.54 | $32.87 | |
| Total debt | $35.96 | $40.96 | $42.69 | |
| Total liabilities | $56.19 | $53.53 | $68.2 | $75.05 |
| Shareholders' equity | ||||
| Retained earnings | -$347.56 | -$345.86 | -$325.14 | -$313.34 |
| Other shareholder equity | -$0.21 | -$0.56 | -$0.57 | -$0.34 |
| Total shareholder equity | $321.44 | $333.4 | $337.66 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $35.44 | $19.47 | $69.87 | $90.46 |
| Short term investments | $16.29 | $43.26 | ||
| Net receivables | $18.66 | $33.94 | $23.22 | $8.01 |
| Inventory | $43.46 | $34.9 | $28.34 | $11.6 |
| Total current assets | $120.6 | $138.45 | $125.86 | $114.71 |
| Long term investments | $5.62 | $6.4 | $4.37 | $5.87 |
| Property, plant & equipment | $40.33 | $48.27 | $46.61 | $24.52 |
| Goodwill & intangible assets | $245.89 | $256.83 | $376.89 | $89.5 |
| Total noncurrent assets | $292.11 | $311.78 | $428.2 | $120.12 |
| Total investments | $21.91 | $49.66 | $4.37 | $5.87 |
| Total assets | $412.71 | $450.23 | $554.06 | $234.83 |
| Current liabilities | ||||
| Accounts payable | $6.94 | $15.37 | $14.95 | $3.67 |
| Deferred revenue | ||||
| Short long term debt | $10.01 | $4.83 | $3.77 | $1.11 |
| Total current liabilities | $42.18 | $44.58 | $40.38 | $15.57 |
| Long term debt | $32.69 | $23.92 | $23.11 | $8.77 |
| Total noncurrent liabilities | $32.87 | $41.46 | $33.54 | $14.01 |
| Total debt | $42.69 | $43.71 | $26.88 | $9.88 |
| Total liabilities | $75.05 | $86.04 | $73.92 | $29.58 |
| Shareholders' equity | ||||
| Retained earnings | -$313.34 | -$246.91 | -$105.02 | -$97.39 |
| Other shareholder equity | -$0.34 | -$0.68 | -$0.28 | |
| Total shareholder equity | $337.66 | $364.19 | $480.14 | $205.25 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $30.57 | $28.33 | $31.73 | $32.73 |
| Cost of revenue | $13.44 | $19.17 | $23.48 | |
| Gross Profit | $16.3 | $14.89 | $12.56 | $9.25 |
| Operating activities | ||||
| Research & development | $2.38 | $3.53 | $4.4 | |
| Selling, general & administrative | $14.4 | $18 | $17.51 | |
| Total operating expenses | $17.85 | $17.69 | $22.69 | $22.82 |
| Operating income | -$2.79 | -$10.13 | -$13.57 | |
| Income from continuing operations | ||||
| EBIT | -$20.36 | -$9.88 | -$12.92 | |
| Income tax expense | -$0.03 | $0.13 | -$0.04 | |
| Interest expense | -$0.27 | $0.36 | $0.21 | $0.51 |
| Net income | ||||
| Net income | -$1.7 | -$20.72 | -$10.22 | -$13.38 |
| Income (for common shares) | -$20.72 | -$10.22 | -$13.38 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $143.27 | $161.76 | $48.09 | |
| Cost of revenue | $96.52 | $107.94 | $20.65 | |
| Gross Profit | $46.75 | $53.82 | $27.44 | |
| Operating activities | ||||
| Research & development | $18.8 | $14.8 | $6.72 | |
| Selling, general & administrative | $80.31 | $69.24 | $21.02 | |
| Total operating expenses | $119.77 | $204.12 | $31.44 | |
| Operating income | -$73.02 | -$150.29 | -$4 | |
| Income from continuing operations | ||||
| EBIT | -$64.45 | -$144.14 | -$0.66 | |
| Income tax expense | $0.17 | -$5.02 | -$3.26 | |
| Interest expense | $1.81 | $0.69 | -$0.06 | |
| Net income | ||||
| Net income | -$66.43 | -$139.81 | $2.67 | |
| Income (for common shares) | -$66.43 | -$139.81 | $2.67 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$20.72 | -$10.22 | -$13.38 | |
| Operating activities | ||||
| Depreciation | $2.36 | $2.28 | $2.29 | |
| Business acquisitions & disposals | -$13.04 | |||
| Stock-based compensation | $8.72 | $6.18 | $8.33 | |
| Total cash flows from operations | $6.46 | -$4.47 | $2.31 | |
| Investing activities | ||||
| Capital expenditures | -$2.13 | -$0.82 | -$2.38 | |
| Investments | $1.73 | $0.6 | $6.34 | |
| Total cash flows from investing | -$15.34 | -$13.44 | -$0.22 | $3.96 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.09 | $10.38 | ||
| Net borrowings | -$0.75 | -$0.97 | -$0.53 | |
| Total cash flows from financing | -$2.7 | -$0.67 | -$0.95 | $9.84 |
| Effect of exchange rate | -$0.03 | $0.06 | ||
| Change in cash and equivalents | -$11.28 | -$5.65 | $16.11 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$66.43 | -$139.81 | -$7.63 | $2.67 |
| Operating activities | ||||
| Depreciation | $12.7 | $19.96 | $14.92 | $5.8 |
| Business acquisitions & disposals | $1.56 | -$16.94 | ||
| Stock-based compensation | $31.67 | $25.33 | $13.96 | $6.04 |
| Total cash flows from operations | -$12.5 | -$8.49 | -$4.59 | $6.64 |
| Investing activities | ||||
| Capital expenditures | -$11.24 | -$13.92 | -$14.75 | -$7.77 |
| Investments | $29.07 | -$44.2 | ||
| Total cash flows from investing | $17.84 | -$58.12 | -$13.19 | -$24.71 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $10.75 | $0.32 | $1.42 | $101.63 |
| Net borrowings | -$0.22 | $16.46 | -$3.93 | $0.98 |
| Total cash flows from financing | $10.59 | $16.32 | -$2.78 | $102.08 |
| Effect of exchange rate | $0.04 | -$0.11 | -$0.02 | |
| Change in cash and equivalents | $15.93 | -$50.29 | -$20.56 | $84.01 |
News
Fundamentals
| Market cap | $896.82M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 46.23M |
| Revenue | $123.36M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$46.02M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -19.49 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 7.27 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$1.00 |
|---|---|
| ROA | -11.72% |
| ROE | N/A |
| Debt/Equity | 0.22 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.78 |
| Quick ratio | 1.78 |